Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to reduce health care-acquired infections, announces a strategic investment by an affiliate of New York-based private investment firm SK Capital Partners (“SK Capital”). SK Capital, which manages a growing portfolio of companies focused on the specialty materials, ingredients, and life sciences sectors, will recapitalize Spectrum in partnership with Spectrum’s existing majority investor, Event Capital Strategies (“ECS”), a medical technology-focused investment firm based in New York. Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024.
Read the full article: SK Capital Makes Strategic Investment in Spectrum Vascular //
Source: https://www.businesswire.com/news/home/20250331115921/en/SK-Capital-Makes-Strategic-Investment-in-Spectrum-Vascular